Effects of TRK-100, a stable prostacyclin analogue, on regulation of cyclic AMP metabolism in platelets
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 37 (2) , 205-212
- https://doi.org/10.1016/0090-6980(89)90057-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Antithrombotic effect of TRK-100, a novel, stable PGI2 analogue.The Japanese Journal of Pharmacology, 1987
- Structure-function relationship of islet-activating protein pertussis toxin: biological activities of hybrid toxins reconstituted from native and methylated subunitsBiochemistry, 1986
- Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the ratProstaglandins, 1986
- Prostacyclin‐analogsMedicinal Research Reviews, 1985
- The use of a prostacyclin analogue, [3H]iloprost, for studying prostacyclin-binding sites on human platelets and neuronal hybrid cellsBioscience Reports, 1984
- G proteins and dual control of adenylate cyclaseCell, 1984
- Differences in the stability of prostacyclin in human, rabbit and rat plasmaProstaglandins, Leukotrienes and Medicine, 1983
- Selective Binding Site for [3H]Prostacyclin on PlateletsJournal of Clinical Investigation, 1979
- Chemical stability of prostacyclin (PGI2) in aqueous solutionsProstaglandins, 1978
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976